Skip to content

Epidemiological characteristics of spinal tuberculosis and molecular characteristics and drug resistance of Mycobacterium tuberculosis in Guangxi Zhuang Autonomous Region

Epidemiological characteristics of spinal tuberculosis and molecular characteristics and drug resistance of Mycobacterium tuberculosis in Guangxi Zhuang Autonomous Region

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400080360
Enrollment
Unknown
Registered
2024-01-26
Start date
2021-01-01
Completion date
Unknown
Last updated
2024-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

spinal tuberculosis

Interventions

Group of spinal tuberculosis:None

Sponsors

The First Affiliated Hospital of Guangxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Spinal tuberculosis patients undergoing surgical treatment at various hospitals in Guangxi.

Exclusion criteria

Exclusion criteria: 1. Specimens with inconsistent results after repeated examination for the same patient; 2. Improper storage, transportation and preservation of specimens or long time (more than 24 hours) after collection of specimens without freezing preservation; 3. The amount of intraoperative specimens collected was small, which could not be separated and cultured; 4. After isolation and culture, there were more miscellaneous bacteria and less mycobacterium tuberculosis, and the samples that could not be purified or the samples had been contaminated.

Design outcomes

Primary

MeasureTime frame
prognosis;

Secondary

MeasureTime frame
State of smoking;State of alcoholism;Clinical manifestations;

Countries

China

Contacts

Public ContactZeng Hao

Department of Spine and Bone Disease, The First Affiliated Hospital of Guangxi Medical University

2621132371@qq.com+86 152 8964 8897

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026